Integrative Omics Analysis of Rheumatoid Arthritis Identifies Non-Obvious Therapeutic Targets

• John W. Whitaker,

  Current address: Discovery Science, Janssen Pharmaceutical of Johnson & Johnson, San Diego, California, United States of America

  Affiliations Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, California, United States of America, Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, California, United States of America

  ⨯
• David L. Boyle,

  Affiliation Division of Rheumatology, Allergy and Immunology, University of California San Diego, La Jolla, California, United States of America

  ⨯
• Beatrix Bartok,

  Affiliation Division of Rheumatology, Allergy and Immunology, University of California San Diego, La Jolla, California, United States of America

  ⨯
• Scott T. Ball,

  Affiliation Department of Orthopaedics, University of California San Diego School of Medicine, La Jolla, California, United States of America

  ⨯
• Steffen Gay,

  Affiliation Department of Rheumatology, University Hospital Zürich, CH-8091, Zurich, Switzerland

  ⨯
• Wei Wang ,

  * E-mail: wei-wang@ucsd.edu (WW); gfirestein@ucsd.edu (GSF)

  Affiliations Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, California, United States of America, Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, California, United States of America

  ⨯
• Gary S. Firestein

  * E-mail: wei-wang@ucsd.edu (WW); gfirestein@ucsd.edu (GSF)

  Affiliation Division of Rheumatology, Allergy and Immunology, University of California San Diego, La Jolla, California, United States of America

  ⨯